Riskpilot← Back to searchSign inGet full accessAscentria Capital AB
ABActiveOrg 5564799525Lyr-Låssbo 320General medical practice activities · NACE 8621Est. 19941 employees
Revenue 2025
SEK 0
EBITDA margin
—
-387% vs 2024
Equity ratio
86.8%
Financial strength
Net profit 2025
SEK -117K
-129% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -234K | -387% |
| Net profit | SEK -117K | -129% |
| Total assets | SEK 2,4M | -5% |
| Equity | SEK 2,1M | -5% |
| Employees | 1 | — |
Legal name
Ascentria Capital AB
Org number
5564799525
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 februari 1994
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska förvalta och handla med värdepapper samt därmed förenlig verksamhet.
Address
Lyr-Låssbo 320
Phone
+46703767546
Email
mikael.krigsman@hpe.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −73 | 122 | −51 | −48 | −234 |
| Depreciation & amort. | −71 | −71 | −2 | −0 | — |
| EBIT | −144 | 51 | −53 | −48 | −234 |
| Net financials | −142 | −334 | −513 | 454 | 117 |
| Profit before tax | −38 | −102 | −285 | 406 | −117 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −38 | −102 | −285 | 406 | −117 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 849 | 2 398 | 2 107 | 2 514 | 2 397 |
| Equity | 2 177 | 2 075 | 1 791 | 2 197 | 2 080 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 672 | 323 | 317 | 317 | 317 |
| Total debt | 672 | 323 | 317 | 317 | 317 |
EBITDA margin
-23370100.0%
This company
15.8%
Market median
-147912125% vs market
20212025
Equity ratio
86.8%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
-5.6%
This company
18.4%
Market median
-130% vs market
20212025
Net profit margin
-11677200.0%
This company
8.1%
Market median
-144163063% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TE Audit | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ascentria Capital AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Erik Berg | Audit | 0 companies |
| Ulf Mikael Krigsman | Board of Directors | 0 companies |
| Sandra Maria Therese Silbo | Deputy Board Member | 0 companies |